Retatrutide 20mg research vial
COA Included ≥99% HPLC Batch Traced Research Grade

Retatrutide 20mg

Triple GLP-1/GIP/Glucagon agonist — 20 mg vial

£98.94 / 20mg vial

For research purposes only. Not for human or veterinary use.

About Retatrutide 20mg

Retatrutide (LY3437943) 20 mg research vial — triple receptor agonist targeting GLP-1, GIP, and glucagon receptors. For advanced metabolic and energy-expenditure research protocols.

Key Research Facts

  • Triple GLP-1/GIP/GcgR agonist
  • 20 mg lyophilised vial
  • Phase 3 compound in clinical development
  • HPLC ≥99% with COA

Reconstitution Protocol

Add 4 mL bacteriostatic water for 5,000 mcg/mL.

Use our peptide reconstitution calculator →

Storage Conditions

Store lyophilised at −20 °C. Reconstituted: 4 °C, use within 21 days.

Certificate of Analysis

Every NewChem batch of Retatrutide is independently tested prior to dispatch. Your COA documents HPLC purity (≥99%), identity confirmation via mass spectrometry, endotoxin screening, and a unique batch ID for full traceability. Sample COAs are available on request before purchase.

Research Guide

For a detailed step-by-step reconstitution guide for Retatrutide, including BAC water measurements, syringe unit conversions, and storage protocols, see our dedicated guide:

How to reconstitute Retatrutide — complete guide →